These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10464099)

  • 1. GTP binding by class II transactivator: role in nuclear import.
    Harton JA; Cressman DE; Chin KC; Der CJ; Ting JP
    Science; 1999 Aug; 285(5432):1402-5. PubMed ID: 10464099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GTP-dependent recruitment of CIITA to the class II major histocompatibility complex promoter.
    Bewry NN; Bolick SC; Wright KL; Harton JA
    J Biol Chem; 2007 Sep; 282(36):26178-84. PubMed ID: 17623662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GTP-binding domain of class II transactivator regulates its nuclear export.
    Raval A; Weissman JD; Howcroft TK; Singer DS
    J Immunol; 2003 Jan; 170(2):922-30. PubMed ID: 12517958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250.
    Raval A; Howcroft TK; Weissman JD; Kirshner S; Zhu XS; Yokoyama K; Ting J; Singer DS
    Mol Cell; 2001 Jan; 7(1):105-15. PubMed ID: 11172716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives: immunology. Regulating the regulator.
    Mach B
    Science; 1999 Aug; 285(5432):1367. PubMed ID: 10490413
    [No Abstract]   [Full Text] [Related]  

  • 6. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
    Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
    Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.
    Mudhasani R; Fontes JD
    Mol Cell Biol; 2002 Jul; 22(14):5019-26. PubMed ID: 12077331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-association of CIITA and its transactivation potential.
    Sisk TJ; Roys S; Chang CH
    Mol Cell Biol; 2001 Aug; 21(15):4919-28. PubMed ID: 11438649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.
    Brown JA; Rogers EM; Boss JM
    Nucleic Acids Res; 1998 Sep; 26(18):4128-36. PubMed ID: 9722631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator.
    Cressman DE; O'Connor WJ; Greer SF; Zhu XS; Ting JP
    J Immunol; 2001 Oct; 167(7):3626-34. PubMed ID: 11564775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.
    Voong LN; Slater AR; Kratovac S; Cressman DE
    J Biol Chem; 2008 Apr; 283(14):9031-9. PubMed ID: 18245089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple interactions between BRG1 and MHC class II promoter binding proteins.
    Mudhasani R; Fontes JD
    Mol Immunol; 2005 Apr; 42(6):673-82. PubMed ID: 15781111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes.
    Spilianakis C; Papamatheakis J; Kretsovali A
    Mol Cell Biol; 2000 Nov; 20(22):8489-98. PubMed ID: 11046145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants.
    Chin KC; Li GG; Ting JP
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2501-6. PubMed ID: 9122224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.
    Beaulieu YB; Leon Machado JA; Ethier S; Gaudreau L; Steimle V
    PLoS One; 2016; 11(2):e0148753. PubMed ID: 26871568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.
    Kanazawa S; Okamoto T; Peterlin BM
    Immunity; 2000 Jan; 12(1):61-70. PubMed ID: 10661406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
    J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine-rich repeats of the class II transactivator control its rate of nuclear accumulation.
    Harton JA; O'Connor W; Conti BJ; Linhoff MW; Ting JP
    Hum Immunol; 2002 Jul; 63(7):588-601. PubMed ID: 12072194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.